Cullinan Therapeutics, Inc. (CGEM) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US2300311063
Cullinan Therapeutics, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -241.65 m USD |
| EBIT | -242.09 m USD |
| Net income | -219.88 m USD |
Full history since 2012, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Cullinan Therapeutics, Inc.
Cullinan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States. It engages in the development of CLN-978, a CD19xCD3 bispecific T cell engager for autoimmune diseases in Phase 1 clinical trials; Velinotamig, a BCMAxCD3 bispecific T cell in Phase 1 clinical trials in patients with autoimmune diseases; and CLN-049, a FLT3xCD3 bispecific T cell engager, which is in Phase 1 clinical trials in patients with relapsed and refractory acute myeloid leukemia or myelodysplastic syndrome. The company is also developing Zipalertinib, an orally available small-molecule, irreversible epidermal growth factor receptor inhibitor in Phase 2b portion of the REZILIENT1 clinical trial in patients with EGFR ex20ins non-small cell lung cancer. It has a license agreement with Chongqing Genrix Biopharmaceutical Co., Ltd to develop and commercialize velinotamig; a co-development agreement with Taiho Pharmaceutical Co., Ltd to develop zipalertinib; and a collaboration agreement with Adimab, LLC to discover and/or optimize antibodies. The company was formerly known as Cullinan Oncology, Inc. and changed its name to Cullinan Therapeutics, Inc. in April 2024. Cullinan Therapeutics, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
More stocks
- Jiangxi Bestoo Energy Co Ltd (001376.SZ)
- Jacquet Metals SA (JCQ.PA)
- Shenzhen L&A Design Holding Limited (300949.SZ)
- Synektik SA (SNT.WA)
- Cyber_Folks SA (CBF.WA)
- Cicor Technologies Ltd (CICN.SW)
- JPmorgan Claverhouse Investment Trust PLC (JCH.L)
- CASS INFORMATION SYSTEMS INC (CASS)
- Hunan Heshun Petroleum Co Ltd (603353.SS)
- Canadian Solar Inc (CSIQ)
- Guilin Layn Natural Ingredients Corp (002166.SZ)
- Yunnan QuakeSafe Seismic Isolation Technologies Co Ltd Class A (300767.SZ)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.